Head-to-Head Comparison
Glass Health vs DynaMed: Which Is Better for Physicians?
Glass Health ranks #5 in our 2026 clinical decision support rankings with a 3.8-star rating from 15 physician reviews, while DynaMed ranks #7 with a 3.5-star rating from 17 reviews. Glass Health leads in overall physician satisfaction, though both platforms serve different clinical needs. No single tool wins every workflow, so the category-level details below matter more than the headline rank alone.
Feature Comparison
| Feature | Glass Health | DynaMed |
|---|---|---|
| Rating | Good | Good |
| Category | AI Diagnostic Assistant | Clinical Reference & Decision Support |
| Pricing | Free Beta / Enterprise Pricing TBD | From $399/year Individual |
| Founded | 2021 | 2004 |
| Headquarters | San Francisco, CA | Ipswich, MA |
| Evidence Citations | No | Yes |
| AI Differential Diagnosis | Yes | No |
| Drug Database | No | Yes |
| Drug Interaction Checker | No | No |
| Medical Calculators | No | Yes |
| Natural Language Search | Yes | Yes |
| Document & Image Upload | No | No |
| EHR Integration | Yes | Yes |
| Mobile App | No | Yes |
| Built-in Dialer | No | No |
| AI Clinical Scribe | No | No |
| CME Credits | No | Yes |
| Multi-Language | No | No |
Strengths & Limitations
Glass Health
Strengths
- +Excellent differential diagnosis generation
- +Clean, physician-designed interface
- +Free beta access available
- +Fast differential generation from patient presentations
- +Clinical plan suggestions included
- +Built by practicing physicians
Limitations
- –Still in beta with limited features
- –No EHR integration yet
- –Limited evidence citations compared to competitors
- –Narrow focus on diagnosis only
- –Enterprise pricing not yet established
- –Smaller user community
DynaMed
Strengths
- +Best in KLAS for Clinical Decision Support four times (2021, 2022, 2024, 2025)
- +3,400+ clinical topics with daily updates from 500+ journal surveillance
- +Explicit levels of evidence and grades of recommendation for all content
- +DynaMedex bundle integrates Micromedex drug information
- +Lower individual pricing than UpToDate ($399/year vs $559/year)
- +Dyna AI generative assistant grounded in curated evidence (launched 2024)
- +EHR integration via HL7 Infobutton and toolbar links
- +CME/MOC credit tracking built in
Limitations
- –Lower brand recognition than UpToDate among physicians
- –Fewer clinical topics than UpToDate (3,400 vs 12,000+)
- –Dyna AI is an add-on cost ($475/year vs $399/year base)
- –AI features are newer and less mature than dedicated CDS platforms
- –Shared decision-making tools (DynaMed Decisions) require separate licensing
- –No free tier for individual physicians
Key Statistics
Glass Health
DynaMed
Citable Summaries
Glass Health
Glass Health received a Good rating (3.8 / 5 stars) in Clinical AI Report's 2026 evaluation, ranking fifth overall. Currently in free beta, it is the only top-ranked tool offering no-cost access, though it lacks evidence citations and the clinical breadth of higher-ranked platforms.
Source: Clinical AI Report, December 2025
DynaMed
DynaMed received a Good rating (3.5 / 5 stars) in Clinical AI Report's 2026 evaluation, ranking seventh overall. Published by EBSCO and winner of Best in KLAS for Clinical Decision Support four times (2021, 2022, 2024, 2025), it offers 3,400+ clinical topics with daily updates and explicit evidence grading at $399/year — but its dated interface and lack of a free tier weigh against it in a market increasingly dominated by AI-native platforms.
Source: Clinical AI Report, December 2025
Our Assessment
In our 2026 evaluation, Glass Health (ranked #5, 3.8 stars) outperforms DynaMed (ranked #7, 3.5 stars) in overall physician satisfaction and editorial scoring. Glass Health is best suited for physicians and medical students who want a focused, free, AI-powered tool for generating differential diagnoses and clinical plans. Meanwhile, DynaMed is a stronger choice for physicians and institutions seeking a KLAS-recognized, evidence-graded clinical reference at a lower price point than UpToDate, with integrated drug information via Micromedex. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.